Travere Therapeutics Inc. (TVTX) NASDAQ
$5.72 (0.08) (-1.38%)
Market Cap: $441.43M
As of 04/19/24 04:00 PM EDT. Market closed.
Travere Therapeutics Inc. (TVTX)
NASDAQ
$5.72
(0.08) (-1.38%)
Market Cap: $441.43M
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
412
URL
Address
.
PRICE CHART FOR TRAVERE THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.74
Previous Close
$5.80
Days Range
$5.58 - $5.91
52 week range
$5.25 - $22.75
Volume
946,702
Avg. Volume (30 days)
1,205,656
Market Cap
$441.43M
Dividend Yield
-
P/E
-
Shares Outstanding
76,108,829
Open
$5.74
Previous Close
$5.80
Days Range
$5.58 - $5.91
52 week range
$5.25 - $22.75
Volume
946,702
Avg. Volume (30 days)
1,205,656
Market Cap
$441.43M
Dividend Yield
-
P/E
-
Shares Outstanding
76,108,829
FINANCIAL STATEMENTS FOR TRAVERE THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR TRAVERE THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Apr 11, 2024 | Sale | $6.74 | 54 | 364 | 70,849 | Apr 12, 2024, 04:05 PM |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Feb 01, 2024 | Sale | $8.70 | 19,122 | 166,435 | 360,616 | Feb 02, 2024, 04:06 PM |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Feb 01, 2024 | Sale | $8.71 | 4,764 | 41,495 | 83,310 | Feb 02, 2024, 04:05 PM |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Feb 01, 2024 | Sale | $8.53 | 2,820 | 24,058 | 52,017 | Feb 02, 2024, 04:05 PM |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Jan 23, 2024 | Sale | $8.96 | 2,062 | 18,476 | 56,034 | Jan 25, 2024, 04:10 PM |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Jan 23, 2024 | Sale | $8.96 | 7,873 | 70,542 | 234,722 | Jan 25, 2024, 04:10 PM |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Jan 23, 2024 | Sale | $9.07 | 853 | 7,735 | 49,721 | Jan 25, 2024, 04:10 PM |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Jan 23, 2024 | Sale | $8.96 | 2,062 | 18,476 | 60,484 | Jan 25, 2024, 04:10 PM |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Jan 23, 2024 | Sale | $9.07 | 910 | 8,252 | 41,337 | Jan 25, 2024, 04:10 PM |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Jan 23, 2024 | Sale | $9.07 | 1,559 | 14,138 | 78,698 | Jan 25, 2024, 04:10 PM |
| Inrig Jula | Chief Medical Officer | Jan 04, 2024 | Sale | $9.17 | 440 | 4,035 | 35,248 | Jan 05, 2024, 04:11 PM |
| Inrig Jula | Chief Medical Officer | Jan 03, 2024 | Sale | $9.48 | 2,069 | 19,613 | 35,688 | Jan 05, 2024, 04:11 PM |
| Heerma Peter | Chief Commercial Officer | Oct 03, 2023 | Sale | $8.25 | 3,091 | 25,504 | 80,257 | Oct 04, 2023, 04:05 PM |
| Cline Christopher R. | Chief Financial Officer | Sep 05, 2023 | Sale | $14.71 | 457 | 6,723 | 50,574 | Sep 05, 2023, 08:15 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Sep 05, 2023 | Sale | $14.71 | 1,815 | 26,699 | 61,173 | Sep 05, 2023, 08:13 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Sep 05, 2023 | Sale | $14.71 | 1,815 | 26,699 | 58,096 | Sep 05, 2023, 08:12 PM |
| Dube Eric M | Chief Executive Officer | Sep 05, 2023 | Sale | $14.71 | 4,455 | 65,533 | 242,595 | Sep 05, 2023, 08:10 PM |
| Cline Christopher R. | Chief Financial Officer | May 10, 2023 | Sale | $16.59 | 455 | 7,548 | 51,031 | May 12, 2023, 04:14 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 10, 2023 | Sale | $16.59 | 825 | 13,687 | 56,611 | May 12, 2023, 04:11 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 10, 2023 | Sale | $16.59 | 825 | 13,687 | 59,211 | May 12, 2023, 04:09 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | May 11, 2023 | Sale | $16.12 | 122 | 1,967 | 42,247 | May 12, 2023, 04:06 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | May 10, 2023 | Sale | $16.59 | 436 | 7,233 | 42,369 | May 12, 2023, 04:06 PM |
| Cline Christopher R. | Chief Financial Officer | Apr 11, 2023 | Sale | $21.49 | 47 | 1,010 | 51,486 | Apr 13, 2023, 04:07 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 01, 2023 | Sale | $22.25 | 2,590 | 57,628 | 57,436 | Feb 02, 2023, 07:11 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 01, 2023 | Sale | $22.25 | 2,590 | 57,628 | 60,036 | Feb 02, 2023, 07:08 PM |
| Heerma Peter | Chief Commercial Officer | Feb 01, 2023 | Sale | $21.75 | 1,779 | 38,697 | 82,069 | Feb 02, 2023, 07:04 PM |
| Cline Christopher R. | Chief Financial Officer | Feb 01, 2023 | Sale | $21.75 | 1,588 | 34,542 | 51,533 | Feb 02, 2023, 07:02 PM |
| Dube Eric M | Chief Executive Officer | Feb 01, 2023 | Sale | $22.25 | 8,196 | 182,361 | 237,150 | Feb 02, 2023, 06:58 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Feb 02, 2023 | Sale | $22.42 | 360 | 8,071 | 42,805 | Feb 02, 2023, 06:53 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Feb 01, 2023 | Sale | $21.75 | 1,671 | 36,348 | 43,165 | Feb 02, 2023, 06:53 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Jan 25, 2023 | Sale | $21.63 | 192 | 4,153 | 34,836 | Jan 26, 2023, 04:05 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Jan 24, 2023 | Sale | $21.90 | 905 | 19,823 | 35,028 | Jan 26, 2023, 04:05 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Jan 24, 2023 | Sale | $21.50 | 2,062 | 44,333 | 42,376 | Jan 26, 2023, 04:05 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 24, 2023 | Sale | $21.50 | 2,062 | 44,333 | 39,776 | Jan 26, 2023, 04:05 PM |
| Dube Eric M | Chief Executive Officer | Jan 24, 2023 | Sale | $21.50 | 6,442 | 138,503 | 147,846 | Jan 26, 2023, 04:05 PM |
| Cline Christopher R. | Chief Financial Officer | Jan 24, 2023 | Sale | $21.90 | 852 | 18,663 | 32,871 | Jan 26, 2023, 04:05 PM |
| Heerma Peter | Chief Commercial Officer | Jan 24, 2023 | Sale | $21.90 | 1,550 | 33,952 | 63,598 | Jan 26, 2023, 04:05 PM |
| Dube Eric M | Chief Executive Officer | Jan 05, 2023 | Sale | $20.75 | 5,625 | 116,719 | 154,288 | Jan 06, 2023, 04:05 PM |
| Inrig Jula | Chief Medical Officer | Jan 05, 2023 | Sale | $20.75 | 442 | 9,172 | 17,507 | Jan 06, 2023, 04:05 PM |
| Inrig Jula | Chief Medical Officer | Jan 04, 2023 | Sale | $20.75 | 2,051 | 42,558 | 17,949 | Jan 06, 2023, 04:05 PM |
| Heerma Peter | Chief Commercial Officer | Oct 04, 2022 | Sale | $25.68 | 3,042 | 78,119 | 65,148 | Oct 06, 2022, 08:10 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | Sep 13, 2022 | Sale | $28.00 | 349 | 9,772 | 35,933 | Sep 15, 2022, 04:05 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 11, 2022 | Sale | $21.71 | 1,563 | 33,940 | 44,485 | May 12, 2022, 08:49 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 12, 2022 | Sale | $21.51 | 1,050 | 22,584 | 41,838 | May 12, 2022, 08:47 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 10, 2022 | Sale | $21.51 | 900 | 19,359 | 42,888 | May 12, 2022, 08:47 PM |
| Clague Laura | Chief Financial Officer | May 11, 2022 | Sale | $21.51 | 1,375 | 29,576 | 35,655 | May 12, 2022, 08:45 PM |
| Clague Laura | Chief Financial Officer | May 10, 2022 | Sale | $21.51 | 825 | 17,746 | 37,030 | May 12, 2022, 08:45 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | May 10, 2022 | Sale | $21.51 | 436 | 9,378 | 36,178 | May 12, 2022, 08:44 PM |
| Calvin Sandra | SVP, Chief Accounting Officer | May 11, 2022 | Sale | $21.92 | 445 | 9,756 | 35,733 | May 12, 2022, 08:44 PM |
| ASELAGE STEVE | Director | May 11, 2022 | Sale | $21.92 | 2,575 | 56,457 | 146,919 | May 12, 2022, 08:35 PM |
| Dube Eric M | Chief Executive Officer | Feb 10, 2022 | Sale | $27.84 | 4,832 | 134,523 | 159,913 | Feb 11, 2022, 04:05 PM |
| Calvin Sandra | VP, Corp Controller and CAO | Jan 31, 2022 | Sale | $26.51 | 798 | 21,152 | 36,614 | Feb 02, 2022, 04:22 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 31, 2022 | Sale | $27.40 | 1,350 | 36,990 | 43,788 | Feb 02, 2022, 04:20 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Jan 31, 2022 | Sale | $27.40 | 1,125 | 30,825 | 45,235 | Feb 02, 2022, 04:19 PM |
| Heerma Peter | Chief Commercial Officer | Jan 31, 2022 | Sale | $27.40 | 1,125 | 30,825 | 67,297 | Feb 02, 2022, 04:18 PM |
| Clague Laura | Chief Financial Officer | Jan 31, 2022 | Sale | $27.40 | 1,238 | 33,921 | 37,855 | Feb 02, 2022, 04:17 PM |
| Dube Eric M | Chief Executive Officer | Jan 31, 2022 | Sale | $27.40 | 4,813 | 131,876 | 164,745 | Feb 02, 2022, 04:16 PM |
| Calvin Sandra | VP, Corp Controller and CAO | Jan 24, 2022 | Sale | $24.58 | 934 | 22,955 | 28,662 | Jan 26, 2022, 04:38 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Jan 24, 2022 | Sale | $24.98 | 1,875 | 46,837 | 36,520 | Jan 26, 2022, 04:37 PM |
| Heerma Peter | Chief Commercial Officer | Jan 24, 2022 | Sale | $24.98 | 1,875 | 46,837 | 58,582 | Jan 26, 2022, 04:36 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 24, 2022 | Sale | $24.98 | 2,250 | 56,205 | 35,298 | Jan 26, 2022, 04:35 PM |
| Clague Laura | Chief Financial Officer | Jan 24, 2022 | Sale | $24.98 | 2,063 | 51,534 | 29,253 | Jan 26, 2022, 04:34 PM |
| Dube Eric M | Chief Executive Officer | Jan 24, 2022 | Sale | $24.98 | 7,873 | 196,668 | 131,710 | Jan 26, 2022, 04:33 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 11, 2022 | Sale | $27.40 | 5,000 | 137,000 | 37,548 | Jan 12, 2022, 04:07 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Jan 11, 2022 | Sale | $27.40 | 2,500 | 68,500 | 38,395 | Jan 12, 2022, 04:06 PM |
| Clague Laura | Chief Financial Officer | Jan 11, 2022 | Sale | $27.40 | 7,500 | 205,500 | 31,316 | Jan 12, 2022, 04:05 PM |
| Dube Eric M | Chief Executive Officer | Jan 04, 2022 | Sale | $30.43 | 4,832 | 147,038 | 152,083 | Jan 06, 2022, 04:03 PM |
| Dube Eric M | Chief Executive Officer | Jan 05, 2022 | Sale | $29.95 | 12,500 | 374,369 | 141,722 | Jan 06, 2022, 04:03 PM |
| ASELAGE STEVE | Director | Nov 16, 2021 | Sale | $29.39 | 31,800 | 934,602 | 149,494 | Nov 18, 2021, 04:08 PM |
| ASELAGE STEVE | Director | Nov 05, 2021 | Option Exercise | $16.23 | 10,000 | 162,300 | 171,794 | Nov 09, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Nov 05, 2021 | Sale | $26.23 | 10,000 | 262,300 | 161,794 | Nov 09, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Nov 02, 2021 | Sale | $30.00 | 3,500 | 105,000 | 19,500 | Nov 03, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Nov 01, 2021 | Sale | $29.48 | 5,000 | 147,400 | 23,000 | Nov 03, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Oct 07, 2021 | Option Exercise | $16.23 | 60,000 | 973,800 | 249,794 | Oct 08, 2021, 04:18 PM |
| ASELAGE STEVE | Director | Oct 07, 2021 | Sale | $26.25 | 60,000 | 1,574,760 | 221,794 | Oct 08, 2021, 04:18 PM |
| Heerma Peter | Chief Commercial Officer | Oct 04, 2021 | Sale | $24.77 | 3,058 | 75,746 | 60,457 | Oct 05, 2021, 04:06 PM |
| Heerma Peter | Chief Commercial Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,086 | 63,515 | Aug 17, 2021, 07:41 PM |
| Dube Eric M | Chief Executive Officer | Aug 17, 2021 | Sale | $17.12 | 7,836 | 134,142 | 156,915 | Aug 17, 2021, 07:40 PM |
| Rosenberg Noah L. | Chief Medical Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 47,614 | Aug 17, 2021, 07:39 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 35,731 | Aug 17, 2021, 07:38 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,086 | 37,548 | Aug 17, 2021, 07:35 PM |
| Clague Laura | Chief Financial Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 31,316 | Aug 17, 2021, 07:34 PM |
| Rosenberg Noah L. | Chief Medical Officer | Jul 28, 2021 | Sale | $13.81 | 1,250 | 17,263 | 44,521 | Jul 29, 2021, 04:09 PM |
| ASELAGE STEVE | Director | Apr 16, 2021 | Option Exercise | $16.23 | 10,000 | 162,300 | 198,940 | Apr 20, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Apr 16, 2021 | Sale | $26.23 | 10,000 | 262,300 | 188,940 | Apr 20, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Mar 17, 2021 | Option Exercise | $16.23 | 10,000 | 162,300 | 206,667 | Mar 19, 2021, 04:05 PM |
| ASELAGE STEVE | Director | Mar 17, 2021 | Sale | $27.44 | 17,727 | 486,456 | 196,667 | Mar 19, 2021, 04:05 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 18, 2021 | Sale | $28.67 | 1,250 | 35,838 | 34,832 | Feb 18, 2021, 06:26 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 17, 2021 | Sale | $27.35 | 1,250 | 34,188 | 36,082 | Feb 18, 2021, 06:26 PM |
| Rosenberg Noah L. | Chief Medical Officer | Feb 08, 2021 | Sale | $31.58 | 1,125 | 35,527 | 46,344 | Feb 09, 2021, 04:32 PM |
| Rosenberg Noah L. | Chief Medical Officer | Feb 05, 2021 | Sale | $31.41 | 1,125 | 35,336 | 47,469 | Feb 09, 2021, 04:32 PM |
| Heerma Peter | Chief Commercial Officer | Feb 08, 2021 | Sale | $31.58 | 1,125 | 35,527 | 59,344 | Feb 09, 2021, 04:31 PM |
| Heerma Peter | Chief Commercial Officer | Feb 05, 2021 | Sale | $31.41 | 1,125 | 35,336 | 60,469 | Feb 09, 2021, 04:31 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 37,332 | Feb 09, 2021, 04:30 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 39,582 | Feb 09, 2021, 04:30 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 37,705 | Feb 09, 2021, 04:30 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 39,955 | Feb 09, 2021, 04:30 PM |
| Clague Laura | Chief Financial Officer | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 32,223 | Feb 09, 2021, 04:29 PM |
| Clague Laura | Chief Financial Officer | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 34,473 | Feb 09, 2021, 04:29 PM |
| Dube Eric M | Chief Executive Officer | Feb 08, 2021 | Sale | $31.58 | 4,813 | 151,995 | 156,813 | Feb 09, 2021, 04:28 PM |
| Dube Eric M | Chief Executive Officer | Feb 05, 2021 | Sale | $31.41 | 4,813 | 151,176 | 161,626 | Feb 09, 2021, 04:28 PM |
| Heerma Peter | Chief Commercial Officer | Feb 03, 2021 | Sale | $28.91 | 563 | 16,276 | 57,094 | Feb 03, 2021, 09:33 PM |
| Heerma Peter | Chief Commercial Officer | Feb 02, 2021 | Sale | $30.75 | 563 | 17,312 | 57,657 | Feb 03, 2021, 09:33 PM |
| Rosenberg Noah L. | Chief Medical Officer | Feb 03, 2021 | Sale | $28.91 | 1,813 | 52,414 | 44,657 | Feb 03, 2021, 09:33 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 03, 2021 | Sale | $28.91 | 3,625 | 104,799 | 38,457 | Feb 03, 2021, 09:32 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 03, 2021 | Sale | $28.91 | 3,175 | 91,789 | 38,380 | Feb 03, 2021, 09:31 PM |
| Clague Laura | Chief Financial Officer | Feb 03, 2021 | Sale | $28.91 | 3,625 | 104,799 | 33,348 | Feb 03, 2021, 09:30 PM |
| Dube Eric M | Chief Executive Officer | Feb 03, 2021 | Sale | $28.91 | 2,406 | 69,557 | 148,939 | Feb 03, 2021, 09:29 PM |
| Rosenberg Noah L. | Chief Medical Officer | Feb 02, 2021 | Sale | $30.75 | 1,813 | 55,750 | 46,470 | Feb 02, 2021, 09:31 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 02, 2021 | Sale | $30.75 | 3,625 | 111,469 | 43,457 | Feb 02, 2021, 09:23 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 02, 2021 | Sale | $30.75 | 3,175 | 97,631 | 41,555 | Feb 02, 2021, 09:21 PM |
| Dube Eric M | Chief Executive Officer | Feb 02, 2021 | Sale | $29.91 | 8,734 | 261,267 | 153,751 | Feb 02, 2021, 09:20 PM |
| Clague Laura | Chief Financial Officer | Feb 02, 2021 | Sale | $30.75 | 3,625 | 111,469 | 36,973 | Feb 02, 2021, 09:19 PM |
| ASELAGE STEVE | Director | Feb 02, 2021 | Option Exercise | $10.09 | 25,000 | 252,250 | 221,667 | Feb 02, 2021, 09:18 PM |
| ASELAGE STEVE | Director | Feb 02, 2021 | Sale | $30.75 | 25,000 | 768,750 | 196,667 | Feb 02, 2021, 09:18 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 05, 2021 | Sale | $26.65 | 688 | 18,335 | 24,743 | Jan 07, 2021, 06:30 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 06, 2021 | Sale | $27.01 | 688 | 18,583 | 24,055 | Jan 07, 2021, 06:30 PM |
| Dube Eric M | Chief Executive Officer | Jan 06, 2021 | Sale | $27.01 | 3,438 | 92,860 | 87,819 | Jan 07, 2021, 06:29 PM |
| Dube Eric M | Chief Executive Officer | Jan 05, 2021 | Sale | $26.65 | 3,438 | 91,623 | 91,257 | Jan 07, 2021, 06:29 PM |
| ASELAGE STEVE | Director | Dec 15, 2020 | Sale | $26.02 | 5,549 | 144,385 | 196,667 | Dec 16, 2020, 08:55 PM |
| ASELAGE STEVE | Director | Dec 02, 2020 | Sale | $23.43 | 7,891 | 184,849 | 202,216 | Dec 04, 2020, 07:00 PM |
| Clague Laura | Chief Financial Officer | Nov 24, 2020 | Sale | $23.86 | 3,750 | 89,475 | 23,223 | Nov 25, 2020, 07:00 PM |
| Clague Laura | Chief Financial Officer | Nov 25, 2020 | Sale | $22.72 | 3,750 | 85,200 | 19,473 | Nov 25, 2020, 07:00 PM |
| Clague Laura | Chief Financial Officer | Nov 16, 2020 | Sale | $23.98 | 7,500 | 179,813 | 19,473 | Nov 17, 2020, 09:00 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Nov 16, 2020 | Sale | $23.96 | 2,500 | 59,900 | 24,086 | Nov 17, 2020, 09:00 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Nov 16, 2020 | Sale | $23.98 | 2,500 | 59,950 | 25,431 | Nov 17, 2020, 09:00 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Nov 13, 2020 | Sale | $23.62 | 2,500 | 59,046 | 27,931 | Nov 13, 2020, 09:26 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Nov 13, 2020 | Sale | $23.62 | 2,500 | 59,056 | 26,586 | Nov 13, 2020, 09:25 PM |
| Clague Laura | Chief Financial Officer | Nov 13, 2020 | Sale | $23.61 | 7,500 | 177,071 | 26,973 | Nov 13, 2020, 09:24 PM |
| ASELAGE STEVE | Director | Nov 06, 2020 | Sale | $23.00 | 20,625 | 474,375 | 213,107 | Nov 06, 2020, 08:56 PM |
| ASELAGE STEVE | Director | Nov 05, 2020 | Sale | $21.26 | 2,500 | 53,150 | 233,732 | Nov 06, 2020, 08:56 PM |
| Heerma Peter | Chief Commercial Officer | Oct 05, 2020 | Sale | $19.35 | 2,188 | 42,338 | 42,329 | Oct 05, 2020, 08:31 PM |
| Heerma Peter | Chief Commercial Officer | Oct 02, 2020 | Sale | $18.90 | 2,188 | 41,353 | 44,517 | Oct 05, 2020, 08:31 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Sep 23, 2020 | Sale | $18.48 | 1,500 | 27,720 | 24,086 | Sep 23, 2020, 08:00 PM |
| Rosenberg Noah L. | Chief Medical Officer | Sep 23, 2020 | Sale | $18.48 | 750 | 13,860 | 27,555 | Sep 23, 2020, 08:00 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Sep 23, 2020 | Sale | $18.48 | 1,500 | 27,720 | 25,431 | Sep 23, 2020, 08:00 PM |
| Clague Laura | Chief Financial Officer | Sep 23, 2020 | Sale | $18.48 | 1,500 | 27,720 | 19,473 | Sep 23, 2020, 08:00 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Sep 22, 2020 | Sale | $18.59 | 1,500 | 27,885 | 25,586 | Sep 22, 2020, 09:20 PM |
| Rosenberg Noah L. | Chief Medical Officer | Sep 22, 2020 | Sale | $18.59 | 750 | 13,943 | 28,305 | Sep 22, 2020, 09:20 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Sep 22, 2020 | Sale | $18.59 | 1,500 | 27,885 | 26,931 | Sep 22, 2020, 09:18 PM |
| Clague Laura | Chief Financial Officer | Sep 22, 2020 | Sale | $18.59 | 1,500 | 27,885 | 20,973 | Sep 22, 2020, 09:18 PM |
| Dube Eric M | Chief Executive Officer | Sep 21, 2020 | Sale | $19.28 | 10,805 | 208,319 | 96,260 | Sep 22, 2020, 09:15 PM |
| ASELAGE STEVE | Director | Aug 05, 2020 | Sale | $19.68 | 2,500 | 49,200 | 236,232 | Aug 06, 2020, 04:07 PM |
| Rosenberg Noah L. | Chief Medical Officer | Jul 28, 2020 | Sale | $20.49 | 870 | 17,826 | 26,055 | Jul 30, 2020, 07:48 PM |
| ASELAGE STEVE | Director | Jun 25, 2020 | Sale | $20.00 | 10,000 | 200,000 | 238,732 | Jun 29, 2020, 09:02 PM |
| ASELAGE STEVE | Director | May 14, 2020 | Sale | $15.09 | 3,062 | 46,206 | 245,732 | May 14, 2020, 08:59 PM |
| ASELAGE STEVE | Director | May 13, 2020 | Sale | $16.41 | 4,063 | 66,674 | 248,794 | May 14, 2020, 08:59 PM |
| ASELAGE STEVE | Director | May 12, 2020 | Sale | $17.16 | 1,000 | 17,160 | 252,857 | May 14, 2020, 08:59 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 11, 2020 | Sale | $14.95 | 525 | 7,849 | 26,483 | May 13, 2020, 09:00 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 12, 2020 | Sale | $17.07 | 1,052 | 17,960 | 25,958 | May 13, 2020, 09:00 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 12, 2020 | Sale | $17.09 | 1,339 | 22,885 | 24,021 | May 13, 2020, 09:00 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 11, 2020 | Sale | $14.95 | 813 | 12,154 | 24,833 | May 13, 2020, 09:00 PM |
| Clague Laura | Chief Financial Officer | May 12, 2020 | Sale | $17.11 | 1,777 | 30,401 | 20,000 | May 13, 2020, 09:00 PM |
| Clague Laura | Chief Financial Officer | May 11, 2020 | Sale | $14.95 | 1,250 | 18,687 | 21,250 | May 13, 2020, 09:00 PM |
| Rosenberg Noah L. | Chief Medical Officer | May 12, 2020 | Sale | $16.98 | 527 | 8,951 | 26,728 | May 13, 2020, 09:00 PM |
| ASELAGE STEVE | Director | May 05, 2020 | Sale | $15.88 | 2,500 | 39,700 | 253,857 | May 06, 2020, 04:09 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Mar 10, 2020 | Sale | $14.87 | 3,250 | 48,327 | 25,646 | Mar 12, 2020, 07:45 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Mar 10, 2020 | Sale | $15.02 | 3,500 | 52,570 | 27,008 | Mar 12, 2020, 07:44 PM |
| Clague Laura | Chief Financial Officer | Mar 10, 2020 | Sale | $15.02 | 4,000 | 60,080 | 22,500 | Mar 12, 2020, 07:43 PM |
| Rosenberg Noah L. | Chief Medical Officer | Mar 05, 2020 | Sale | $15.36 | 1,790 | 27,487 | 27,255 | Mar 09, 2020, 09:05 PM |
| ASELAGE STEVE | Director | Mar 05, 2020 | Sale | $15.36 | 4,359 | 66,939 | 256,357 | Mar 09, 2020, 09:03 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 18, 2020 | Sale | $16.55 | 1,250 | 20,687 | 25,646 | Feb 19, 2020, 04:05 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 14, 2020 | Sale | $16.72 | 1,250 | 20,900 | 26,896 | Feb 19, 2020, 04:05 PM |
| ASELAGE STEVE | Director | Feb 05, 2020 | Sale | $16.62 | 2,500 | 41,550 | 248,466 | Feb 07, 2020, 07:38 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 08, 2020 | Sale | $15.14 | 750 | 11,355 | 18,008 | Jan 08, 2020, 09:01 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 07, 2020 | Sale | $13.94 | 750 | 10,455 | 18,758 | Jan 08, 2020, 09:01 PM |
| Dube Eric M | Chief Executive Officer | Jan 08, 2020 | Sale | $15.14 | 3,750 | 56,775 | 42,500 | Jan 08, 2020, 08:49 PM |
| Dube Eric M | Chief Executive Officer | Jan 07, 2020 | Sale | $13.94 | 3,750 | 52,275 | 46,250 | Jan 08, 2020, 08:49 PM |
| ASELAGE STEVE | Director | Nov 29, 2019 | Sale | $13.91 | 5,000 | 69,552 | 250,966 | Nov 29, 2019, 09:27 PM |
| Rosenberg Noah L. | Chief Medical Officer | Jul 31, 2019 | Sale | $20.07 | 1,250 | 25,087 | 13,500 | Jul 31, 2019, 09:15 PM |
| Rosenberg Noah L. | Chief Medical Officer | Jul 30, 2019 | Sale | $19.82 | 1,250 | 24,775 | 14,750 | Jul 31, 2019, 09:15 PM |
| McFarlane Neil F. | Chief Operating Officer | May 15, 2019 | Sale | $17.78 | 984 | 17,496 | 27,972 | May 16, 2019, 09:37 PM |
| McFarlane Neil F. | Chief Operating Officer | May 16, 2019 | Sale | $18.71 | 984 | 18,411 | 26,988 | May 16, 2019, 09:37 PM |
| Clague Laura | Chief Financial Officer | May 16, 2019 | Sale | $18.71 | 1,250 | 23,387 | 13,500 | May 16, 2019, 09:37 PM |
| Clague Laura | Chief Financial Officer | May 15, 2019 | Sale | $17.78 | 1,250 | 22,225 | 14,750 | May 16, 2019, 09:37 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 15, 2019 | Sale | $17.76 | 812 | 14,421 | 18,185 | May 16, 2019, 09:36 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | May 14, 2019 | Sale | $17.78 | 813 | 14,455 | 18,997 | May 16, 2019, 09:36 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 15, 2019 | Sale | $17.71 | 525 | 9,298 | 19,508 | May 16, 2019, 09:35 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | May 14, 2019 | Sale | $17.75 | 525 | 9,319 | 20,033 | May 16, 2019, 09:35 PM |
| ASELAGE STEVE | Director | May 14, 2019 | Sale | $17.79 | 1,838 | 32,698 | 257,804 | May 16, 2019, 09:34 PM |
| ASELAGE STEVE | Director | May 15, 2019 | Sale | $17.82 | 1,838 | 32,753 | 255,966 | May 16, 2019, 09:34 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 19, 2019 | Sale | $21.52 | 1,250 | 26,900 | 13,810 | Feb 20, 2019, 07:58 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 15, 2019 | Sale | $21.44 | 1,250 | 26,800 | 15,060 | Feb 20, 2019, 07:58 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 12, 2019 | Sale | $21.50 | 884 | 19,006 | 14,558 | Feb 13, 2019, 08:50 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 11, 2019 | Sale | $21.38 | 885 | 18,921 | 15,442 | Feb 13, 2019, 08:50 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 12, 2019 | Sale | $21.50 | 992 | 21,328 | 16,007 | Feb 13, 2019, 08:49 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 11, 2019 | Sale | $21.38 | 993 | 21,230 | 16,999 | Feb 13, 2019, 08:49 PM |
| Clague Laura | Chief Financial Officer | Feb 12, 2019 | Sale | $21.50 | 1,016 | 21,844 | 10,000 | Feb 13, 2019, 08:49 PM |
| Clague Laura | Chief Financial Officer | Feb 11, 2019 | Sale | $21.38 | 1,017 | 21,743 | 11,016 | Feb 13, 2019, 08:49 PM |
| ASELAGE STEVE | Chief Executive Officer | Feb 12, 2019 | Sale | $21.50 | 1,065 | 22,898 | 257,642 | Feb 13, 2019, 08:47 PM |
| ASELAGE STEVE | Chief Executive Officer | Feb 11, 2019 | Sale | $21.38 | 1,065 | 22,770 | 258,707 | Feb 13, 2019, 08:47 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 09, 2019 | Sale | $23.82 | 750 | 17,865 | 16,327 | Jan 09, 2019, 07:43 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 08, 2019 | Sale | $24.09 | 750 | 18,068 | 17,077 | Jan 09, 2019, 07:43 PM |
| McFarlane Neil F. | Chief Operating Officer | Dec 20, 2018 | Sale | $22.32 | 11,125 | 248,333 | 35,360 | Dec 21, 2018, 08:21 PM |
| ASELAGE STEVE | Chief Executive Officer | Dec 21, 2018 | Sale | $21.79 | 6,188 | 134,829 | 260,672 | Dec 21, 2018, 08:20 PM |
| ASELAGE STEVE | Chief Executive Officer | Dec 20, 2018 | Sale | $21.97 | 6,188 | 135,958 | 265,960 | Dec 21, 2018, 08:20 PM |
| Clague Laura | Chief Financial Officer | Dec 21, 2018 | Sale | $21.83 | 3,750 | 81,860 | 12,933 | Dec 21, 2018, 08:19 PM |
| Clague Laura | Chief Financial Officer | Dec 20, 2018 | Sale | $22.08 | 3,750 | 82,804 | 15,783 | Dec 21, 2018, 08:19 PM |
| ASELAGE STEVE | Chief Executive Officer | Dec 07, 2018 | Sale | $24.04 | 10 | 240 | 251,523 | Dec 07, 2018, 09:15 PM |
| McFarlane Neil F. | Chief Operating Officer | Nov 14, 2018 | Sale | $23.73 | 10,000 | 237,314 | 29,476 | Nov 16, 2018, 07:19 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Nov 15, 2018 | Sale | $24.33 | 2,500 | 60,816 | 18,027 | Nov 16, 2018, 07:18 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Nov 14, 2018 | Sale | $23.73 | 2,500 | 59,330 | 20,627 | Nov 16, 2018, 07:18 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Nov 15, 2018 | Sale | $24.32 | 2,500 | 60,800 | 18,304 | Nov 16, 2018, 07:17 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Nov 14, 2018 | Sale | $23.73 | 2,500 | 59,329 | 20,792 | Nov 16, 2018, 07:17 PM |
| Clague Laura | Chief Financial Officer | Nov 15, 2018 | Sale | $24.31 | 3,750 | 91,167 | 12,824 | Nov 16, 2018, 07:16 PM |
| Clague Laura | Chief Financial Officer | Nov 14, 2018 | Sale | $23.73 | 3,750 | 88,970 | 16,183 | Nov 16, 2018, 07:16 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 15, 2018 | Sale | $24.32 | 5,550 | 134,969 | 254,369 | Nov 16, 2018, 07:16 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 14, 2018 | Sale | $23.74 | 5,550 | 131,735 | 259,433 | Nov 16, 2018, 07:16 PM |
| ASELAGE STEVE | Chief Executive Officer | Aug 31, 2018 | Option Exercise | $8.70 | 12,000 | 104,400 | 257,883 | Aug 31, 2018, 07:54 PM |
| ASELAGE STEVE | Chief Executive Officer | Aug 31, 2018 | Sale | $32.00 | 12,000 | 384,000 | 245,883 | Aug 31, 2018, 07:54 PM |
| ASELAGE STEVE | Chief Executive Officer | Mar 07, 2018 | Option Exercise | $6.00 | 278 | 1,668 | 221,383 | Mar 08, 2018, 09:13 PM |
| ROTE WILLIAM E. | Senior Vice President, R&D | Feb 14, 2018 | Sale | $21.50 | 1,034 | 22,232 | 11,156 | Feb 16, 2018, 07:39 PM |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 05, 2018 | Sale | $24.04 | 942 | 22,646 | 9,058 | Jan 08, 2018, 07:58 PM |
| McFarlane Neil F. | Chief Operating Officer | Aug 16, 2017 | Sale | $22.50 | 1,378 | 31,005 | 13,622 | Aug 17, 2017, 08:36 PM |
| ASELAGE STEVE | Chief Executive Officer | Jun 14, 2017 | Buy | $17.85 | 5,000 | 89,250 | 245,556 | Jun 14, 2017, 02:40 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 22, 2016 | Sale | $21.30 | 3,200 | 68,160 | 240,556 | Nov 23, 2016, 04:25 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 21, 2016 | Sale | $21.00 | 5,000 | 105,000 | 243,756 | Nov 23, 2016, 04:25 PM |
| Shih Alvin | EVP of Research & Development | Sep 01, 2016 | Sale | $16.24 | 8,750 | 142,059 | 158,334 | Sep 02, 2016, 09:26 PM |
| Shih Alvin | EVP of Research & Development | Jun 01, 2016 | Sale | $17.75 | 8,750 | 155,284 | 167,084 | Jun 02, 2016, 09:04 PM |
| Meckler Jeffrey A | Director | Mar 04, 2016 | Buy | $15.31 | 5,000 | 76,564 | 52,000 | Mar 07, 2016, 08:50 PM |
| Meckler Jeffrey A | Director | Mar 03, 2016 | Buy | $14.45 | 10,000 | 144,500 | 47,000 | Mar 03, 2016, 06:49 PM |
| Shih Alvin | EVP of Research & Development | Mar 01, 2016 | Sale | $14.35 | 8,750 | 125,569 | 175,834 | Mar 01, 2016, 06:35 PM |
| Shih Alvin | EVP of Research & Development | Dec 09, 2015 | Sale | $20.83 | 8,750 | 182,262 | 184,584 | Dec 10, 2015, 08:50 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 10, 2015 | Sale | $18.72 | 30,000 | 561,600 | 308,756 | Nov 12, 2015, 01:03 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 09, 2015 | Sale | $18.77 | 30,000 | 563,100 | 338,756 | Nov 12, 2015, 01:03 PM |
| VALEUR JENSEN MARGARET E | General Counsel | Nov 02, 2015 | Sale | $20.46 | 50,000 | 1,022,949 | 55,336 | Nov 04, 2015, 07:04 PM |
| Shih Alvin | EVP of Research & Development | Oct 06, 2015 | Sale | $20.12 | 8,750 | 176,073 | 197,286 | Oct 08, 2015, 09:49 PM |
| Shih Alvin | EVP of Research & Development | Jun 26, 2015 | Sale | $32.70 | 27,916 | 912,850 | 202,084 | Jun 30, 2015, 05:32 PM |
| Plotkin Horacio | Chief Medical Officer | Dec 12, 2014 | Sale | $10.07 | 2,100 | 21,146 | 91,767 | Dec 16, 2014, 02:30 PM |
| Meckler Jeffrey A | Director | Nov 25, 2014 | Buy | $8.60 | 15,000 | 129,050 | 35,000 | Nov 25, 2014, 03:16 PM |
| Richardson Steven Gary | Director | Nov 21, 2014 | Buy | $8.38 | 6,100 | 51,118 | 129,165 | Nov 24, 2014, 07:43 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 20, 2014 | Sale | $8.23 | 134,354 | 1,105,989 | 2,018,015 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 19, 2014 | Sale | $8.54 | 329,824 | 2,817,093 | 2,152,369 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 18, 2014 | Sale | $9.19 | 254,975 | 2,343,501 | 2,482,193 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 17, 2014 | Sale | $9.41 | 100,000 | 941,100 | 2,737,168 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 14, 2014 | Sale | $10.23 | 100,000 | 1,022,790 | 2,837,168 | Nov 24, 2014, 02:55 PM |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | Nov 21, 2014 | Sale | $8.41 | 252,847 | 2,126,443 | 1,765,168 | Nov 24, 2014, 02:55 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 20, 2014 | Buy | $8.20 | 1,300 | 10,660 | 363,056 | Nov 21, 2014, 06:02 PM |
| ASELAGE STEVE | Chief Executive Officer | Nov 21, 2014 | Buy | $8.50 | 8,700 | 73,950 | 371,756 | Nov 21, 2014, 06:02 PM |
| Golding Cornelius E | Director | Nov 19, 2014 | Buy | $9.00 | 2,000 | 18,000 | 25,000 | Nov 19, 2014, 05:39 PM |
| Plotkin Horacio | Chief Medical Officer | Nov 17, 2014 | Sale | $9.43 | 8,333 | 78,594 | 93,867 | Nov 19, 2014, 05:37 PM |
| Shkreli Martin | Chief Executive Officer | Oct 01, 2014 | Buy | $8.11 | 25,000 | 202,665 | 2,962,168 | Oct 09, 2014, 11:11 AM |
| Shkreli Martin | Chief Executive Officer | Oct 01, 2014 | Sale | $0.01 | 300,000 | 3,000 | 2,662,168 | Oct 09, 2014, 11:11 AM |
| Shkreli Martin | Chief Executive Officer | Sep 30, 2014 | Buy | $9.42 | 4,000 | 37,680 | 2,937,168 | Oct 02, 2014, 09:30 PM |
| Shkreli Martin | Chief Executive Officer | Sep 22, 2014 | Buy | $10.82 | 35,000 | 378,707 | 2,933,168 | Sep 23, 2014, 10:54 AM |
| Shkreli Martin | Chief Executive Officer | Sep 19, 2014 | Buy | $11.78 | 18,000 | 212,035 | 2,898,168 | Sep 23, 2014, 10:54 AM |
| Shkreli Martin | Chief Executive Officer | Sep 17, 2014 | Buy | $11.46 | 6,000 | 68,740 | 2,880,168 | Sep 18, 2014, 11:28 AM |
| Shkreli Martin | Chief Executive Officer | Sep 16, 2014 | Buy | $10.69 | 7,500 | 80,190 | 2,874,168 | Sep 16, 2014, 07:51 PM |
| Paley Jeffrey | Director | Aug 14, 2014 | Sale | $12.28 | 20,000 | 245,598 | 51,665 | Aug 18, 2014, 05:51 PM |
| Shkreli Martin | Chief Executive Officer | May 30, 2014 | Option Exercise | $14.62 | 176,388 | 2,578,793 | 3,159,068 | Jun 03, 2014, 09:50 PM |
| Shkreli Martin | Chief Executive Officer | May 30, 2014 | Sale | $15.14 | 292,400 | 4,426,936 | 2,866,668 | Jun 03, 2014, 09:50 PM |
| Shkreli Martin | Chief Executive Officer | Apr 04, 2014 | Buy | $19.64 | 8,000 | 157,145 | 2,982,680 | Apr 07, 2014, 10:16 AM |
| Shkreli Martin | Chief Executive Officer | Apr 03, 2014 | Buy | $22.60 | 22,500 | 508,442 | 2,974,680 | Apr 04, 2014, 11:53 AM |
| Shkreli Martin | Chief Executive Officer | Apr 02, 2014 | Buy | $22.28 | 10,800 | 240,615 | 2,952,180 | Apr 03, 2014, 09:34 AM |
| Shkreli Martin | Chief Executive Officer | Mar 24, 2014 | Buy | $17.61 | 4,000 | 70,440 | 2,941,380 | Mar 27, 2014, 10:20 AM |
| Shkreli Martin | Chief Executive Officer | Mar 20, 2014 | Buy | $17.97 | 5,000 | 89,850 | 2,937,380 | Mar 21, 2014, 01:36 PM |
| Shkreli Martin | Chief Executive Officer | Mar 19, 2014 | Buy | $18.44 | 3,500 | 64,557 | 2,932,380 | Mar 20, 2014, 12:24 PM |
| Shkreli Martin | Chief Executive Officer | Mar 14, 2014 | Buy | $17.36 | 4,000 | 69,445 | 2,928,880 | Mar 17, 2014, 04:15 PM |
| Shkreli Martin | Chief Executive Officer | Mar 11, 2014 | Buy | $19.47 | 25,900 | 504,387 | 2,924,880 | Mar 12, 2014, 09:49 AM |
| Shkreli Martin | Chief Executive Officer | Mar 10, 2014 | Buy | $19.32 | 10,700 | 206,711 | 2,898,980 | Mar 11, 2014, 10:45 AM |
| Shkreli Martin | Chief Executive Officer | Mar 07, 2014 | Buy | $18.26 | 2,498 | 45,618 | 2,888,280 | Mar 10, 2014, 10:20 AM |
| Shkreli Martin | Chief Executive Officer | Mar 06, 2014 | Buy | $18.93 | 1,560 | 29,528 | 2,885,782 | Mar 10, 2014, 10:20 AM |
| Shkreli Martin | Chief Executive Officer | Mar 05, 2014 | Buy | $18.48 | 4,000 | 73,906 | 2,884,222 | Mar 06, 2014, 09:32 AM |
| Shkreli Martin | Chief Executive Officer | Feb 21, 2014 | Buy | $17.20 | 100 | 1,720 | 2,837,222 | Mar 03, 2014, 10:00 AM |
| Shkreli Martin | Chief Executive Officer | Feb 28, 2014 | Buy | $18.67 | 43,000 | 802,677 | 2,880,222 | Mar 03, 2014, 10:00 AM |
| Shkreli Martin | Chief Executive Officer | Feb 21, 2014 | Buy | $17.56 | 1,600 | 28,102 | 2,837,122 | Feb 25, 2014, 09:00 AM |
| Shkreli Martin | Chief Executive Officer | Feb 14, 2014 | Buy | $14.60 | 3,500 | 51,106 | 2,835,522 | Feb 19, 2014, 10:40 AM |
| Shkreli Martin | Chief Executive Officer | Feb 06, 2014 | Buy | $9.92 | 2,000 | 19,832 | 2,832,022 | Feb 07, 2014, 12:52 PM |
| Shkreli Martin | Chief Executive Officer | Jan 14, 2014 | Buy | $10.84 | 8,000 | 86,694 | 2,830,022 | Jan 15, 2014, 06:01 AM |
| Shkreli Martin | Chief Executive Officer | Sep 12, 2013 | Buy | $4.50 | 5,556 | 25,002 | 2,665,596 | Jan 14, 2014, 07:04 PM |
| Shkreli Martin | Chief Executive Officer | Dec 31, 2013 | Buy | $7.00 | 150,000 | 1,050,000 | 2,816,246 | Jan 02, 2014, 06:41 AM |
| Richardson Steven Gary | Director | Aug 15, 2013 | Buy | $4.50 | 1,110 | 4,995 | 99,165 | Dec 30, 2013, 04:30 PM |
| ASELAGE STEVE | Director | Aug 15, 2013 | Buy | $4.50 | 556 | 2,502 | 261,756 | Dec 27, 2013, 07:59 PM |
| Golding Cornelius E | Director | Dec 24, 2013 | Buy | $7.50 | 3,000 | 22,500 | 3,000 | Dec 27, 2013, 04:04 PM |
| Shkreli Martin | Chief Executive Officer | Dec 09, 2013 | Buy | $8.11 | 100 | 811 | 2,666,246 | Dec 10, 2013, 02:33 PM |
| Shkreli Martin | Chief Executive Officer | Dec 06, 2013 | Buy | $8.30 | 100 | 830 | 2,666,146 | Dec 10, 2013, 02:33 PM |
| Shkreli Martin | Chief Executive Officer | Nov 26, 2013 | Buy | $6.81 | 150 | 1,021 | 2,666,046 | Dec 02, 2013, 03:51 PM |
| Shkreli Martin | Chief Executive Officer | Nov 22, 2013 | Buy | $6.06 | 300 | 1,818 | 2,665,896 | Dec 02, 2013, 03:51 PM |
| Richardson Steven Gary | Director | Nov 05, 2013 | Buy | $6.90 | 2,900 | 20,010 | 102,065 | Nov 08, 2013, 06:09 PM |
| Shkreli Martin | Chief Executive Officer | Sep 12, 2013 | Buy | $4.50 | 11,112 | 50,004 | 2,671,152 | Sep 16, 2013, 05:11 PM |
| Plotkin Horacio | Chief Medical Officer | Aug 15, 2013 | Buy | $4.50 | 2,200 | 9,900 | 2,200 | Aug 23, 2013, 02:15 PM |
| Shkreli Martin | Chief Executive Officer | Aug 21, 2013 | Buy | $6.08 | 2,800 | 17,024 | 2,658,940 | Aug 23, 2013, 02:15 PM |
| Shkreli Martin | Chief Executive Officer | Aug 22, 2013 | Buy | $6.02 | 1,100 | 6,622 | 2,660,040 | Aug 23, 2013, 02:15 PM |
| PANOFF MARC L | Chief Financial Officer | Aug 15, 2013 | Buy | $4.50 | 1,100 | 4,950 | 121,100 | Aug 20, 2013, 05:33 PM |
| Shkreli Martin | Chief Executive Officer | Mar 11, 2013 | Buy | $4.70 | 400 | 1,880 | 2,656,140 | Mar 12, 2013, 01:31 PM |
| Shkreli Martin | Chief Executive Officer | Mar 06, 2013 | Buy | $4.25 | 100 | 425 | 2,655,740 | Mar 12, 2013, 01:31 PM |
| Shkreli Martin | Chief Executive Officer | Mar 04, 2013 | Buy | $4.43 | 1,000 | 4,425 | 2,655,640 | Mar 06, 2013, 02:21 PM |
| Shkreli Martin | Chief Executive Officer | Feb 20, 2013 | Buy | $4.16 | 1,120 | 4,662 | 2,654,640 | Feb 21, 2013, 02:44 PM |
| Shkreli Martin | Chief Executive Officer | Feb 14, 2013 | Buy | $3.00 | 120,000 | 360,000 | 2,653,520 | Feb 19, 2013, 04:14 PM |
| Shkreli Martin | Chief Executive Officer | Feb 12, 2013 | Buy | $3.57 | 1,400 | 5,000 | 2,533,520 | Feb 13, 2013, 06:41 PM |
| Shkreli Martin | Chief Executive Officer | Dec 26, 2012 | Buy | $3.55 | 100 | 355 | 2,532,120 | Dec 28, 2012, 12:30 PM |
| Shkreli Martin | Chief Executive Officer | Dec 17, 2012 | Buy | $7.69 | 100 | 769 | 2,532,020 | Dec 28, 2012, 12:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 04/11/2024 | 364 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 02/01/2024 | 166,435 |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 02/01/2024 | 41,495 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 02/01/2024 | 24,058 |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 01/23/2024 | 18,476 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 01/23/2024 | 70,542 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 01/23/2024 | 7,735 |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 01/23/2024 | 18,476 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 01/23/2024 | 8,252 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 01/23/2024 | 14,138 |
| Inrig Jula | Chief Medical Officer | 01/04/2024 | 4,035 |
| Inrig Jula | Chief Medical Officer | 01/03/2024 | 19,613 |
| Heerma Peter | Chief Commercial Officer | 10/03/2023 | 25,504 |
| Cline Christopher R. | Chief Financial Officer | 09/05/2023 | 6,723 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 09/05/2023 | 26,699 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 09/05/2023 | 26,699 |
| Dube Eric M | Chief Executive Officer | 09/05/2023 | 65,533 |
| Cline Christopher R. | Chief Financial Officer | 05/10/2023 | 7,548 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/10/2023 | 13,687 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/10/2023 | 13,687 |
| Calvin Sandra | SVP, Chief Accounting Officer | 05/11/2023 | 1,967 |
| Calvin Sandra | SVP, Chief Accounting Officer | 05/10/2023 | 7,233 |
| Cline Christopher R. | Chief Financial Officer | 04/11/2023 | 1,010 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/01/2023 | 57,628 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/01/2023 | 57,628 |
| Heerma Peter | Chief Commercial Officer | 02/01/2023 | 38,697 |
| Cline Christopher R. | Chief Financial Officer | 02/01/2023 | 34,542 |
| Dube Eric M | Chief Executive Officer | 02/01/2023 | 182,361 |
| Calvin Sandra | SVP, Chief Accounting Officer | 02/02/2023 | 8,071 |
| Calvin Sandra | SVP, Chief Accounting Officer | 02/01/2023 | 36,348 |
| Calvin Sandra | SVP, Chief Accounting Officer | 01/25/2023 | 4,153 |
| Calvin Sandra | SVP, Chief Accounting Officer | 01/24/2023 | 19,823 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 01/24/2023 | 44,333 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/24/2023 | 44,333 |
| Dube Eric M | Chief Executive Officer | 01/24/2023 | 138,503 |
| Cline Christopher R. | Chief Financial Officer | 01/24/2023 | 18,663 |
| Heerma Peter | Chief Commercial Officer | 01/24/2023 | 33,952 |
| Dube Eric M | Chief Executive Officer | 01/05/2023 | 116,719 |
| Inrig Jula | Chief Medical Officer | 01/05/2023 | 9,172 |
| Inrig Jula | Chief Medical Officer | 01/04/2023 | 42,558 |
| Heerma Peter | Chief Commercial Officer | 10/04/2022 | 78,119 |
| Calvin Sandra | SVP, Chief Accounting Officer | 09/13/2022 | 9,772 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/11/2022 | 33,940 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/12/2022 | 22,584 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/10/2022 | 19,359 |
| Clague Laura | Chief Financial Officer | 05/11/2022 | 29,576 |
| Clague Laura | Chief Financial Officer | 05/10/2022 | 17,746 |
| Calvin Sandra | SVP, Chief Accounting Officer | 05/10/2022 | 9,378 |
| Calvin Sandra | SVP, Chief Accounting Officer | 05/11/2022 | 9,756 |
| ASELAGE STEVE | Director | 05/11/2022 | 56,457 |
| Dube Eric M | Chief Executive Officer | 02/10/2022 | 134,523 |
| Calvin Sandra | VP, Corp Controller and CAO | 01/31/2022 | 21,152 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/31/2022 | 36,990 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 01/31/2022 | 30,825 |
| Heerma Peter | Chief Commercial Officer | 01/31/2022 | 30,825 |
| Clague Laura | Chief Financial Officer | 01/31/2022 | 33,921 |
| Dube Eric M | Chief Executive Officer | 01/31/2022 | 131,876 |
| Calvin Sandra | VP, Corp Controller and CAO | 01/24/2022 | 22,955 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 01/24/2022 | 46,837 |
| Heerma Peter | Chief Commercial Officer | 01/24/2022 | 46,837 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/24/2022 | 56,205 |
| Clague Laura | Chief Financial Officer | 01/24/2022 | 51,534 |
| Dube Eric M | Chief Executive Officer | 01/24/2022 | 196,668 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/11/2022 | 137,000 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 01/11/2022 | 68,500 |
| Clague Laura | Chief Financial Officer | 01/11/2022 | 205,500 |
| Dube Eric M | Chief Executive Officer | 01/04/2022 | 147,038 |
| Dube Eric M | Chief Executive Officer | 01/05/2022 | 374,369 |
| ASELAGE STEVE | Director | 11/16/2021 | 934,602 |
| ASELAGE STEVE | Director | 11/05/2021 | 162,300 |
| ASELAGE STEVE | Director | 11/05/2021 | 262,300 |
| ASELAGE STEVE | Director | 11/02/2021 | 105,000 |
| ASELAGE STEVE | Director | 11/01/2021 | 147,400 |
| ASELAGE STEVE | Director | 10/07/2021 | 973,800 |
| ASELAGE STEVE | Director | 10/07/2021 | 1,574,760 |
| Heerma Peter | Chief Commercial Officer | 10/04/2021 | 75,746 |
| Heerma Peter | Chief Commercial Officer | 08/17/2021 | 24,086 |
| Dube Eric M | Chief Executive Officer | 08/17/2021 | 134,142 |
| Rosenberg Noah L. | Chief Medical Officer | 08/17/2021 | 24,085 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 08/17/2021 | 24,085 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 08/17/2021 | 24,086 |
| Clague Laura | Chief Financial Officer | 08/17/2021 | 24,085 |
| Rosenberg Noah L. | Chief Medical Officer | 07/28/2021 | 17,263 |
| ASELAGE STEVE | Director | 04/16/2021 | 162,300 |
| ASELAGE STEVE | Director | 04/16/2021 | 262,300 |
| ASELAGE STEVE | Director | 03/17/2021 | 162,300 |
| ASELAGE STEVE | Director | 03/17/2021 | 486,456 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/18/2021 | 35,838 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/17/2021 | 34,188 |
| Rosenberg Noah L. | Chief Medical Officer | 02/08/2021 | 35,527 |
| Rosenberg Noah L. | Chief Medical Officer | 02/05/2021 | 35,336 |
| Heerma Peter | Chief Commercial Officer | 02/08/2021 | 35,527 |
| Heerma Peter | Chief Commercial Officer | 02/05/2021 | 35,336 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/08/2021 | 71,055 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/05/2021 | 70,672 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/08/2021 | 71,055 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/05/2021 | 70,672 |
| Clague Laura | Chief Financial Officer | 02/08/2021 | 71,055 |
| Clague Laura | Chief Financial Officer | 02/05/2021 | 70,672 |
| Dube Eric M | Chief Executive Officer | 02/08/2021 | 151,995 |
| Dube Eric M | Chief Executive Officer | 02/05/2021 | 151,176 |
| Heerma Peter | Chief Commercial Officer | 02/03/2021 | 16,276 |
| Heerma Peter | Chief Commercial Officer | 02/02/2021 | 17,312 |
| Rosenberg Noah L. | Chief Medical Officer | 02/03/2021 | 52,414 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/03/2021 | 104,799 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/03/2021 | 91,789 |
| Clague Laura | Chief Financial Officer | 02/03/2021 | 104,799 |
| Dube Eric M | Chief Executive Officer | 02/03/2021 | 69,557 |
| Rosenberg Noah L. | Chief Medical Officer | 02/02/2021 | 55,750 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/02/2021 | 111,469 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/02/2021 | 97,631 |
| Dube Eric M | Chief Executive Officer | 02/02/2021 | 261,267 |
| Clague Laura | Chief Financial Officer | 02/02/2021 | 111,469 |
| ASELAGE STEVE | Director | 02/02/2021 | 252,250 |
| ASELAGE STEVE | Director | 02/02/2021 | 768,750 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/05/2021 | 18,335 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/06/2021 | 18,583 |
| Dube Eric M | Chief Executive Officer | 01/06/2021 | 92,860 |
| Dube Eric M | Chief Executive Officer | 01/05/2021 | 91,623 |
| ASELAGE STEVE | Director | 12/15/2020 | 144,385 |
| ASELAGE STEVE | Director | 12/02/2020 | 184,849 |
| Clague Laura | Chief Financial Officer | 11/24/2020 | 89,475 |
| Clague Laura | Chief Financial Officer | 11/25/2020 | 85,200 |
| Clague Laura | Chief Financial Officer | 11/16/2020 | 179,813 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 11/16/2020 | 59,900 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 11/16/2020 | 59,950 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 11/13/2020 | 59,046 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 11/13/2020 | 59,056 |
| Clague Laura | Chief Financial Officer | 11/13/2020 | 177,071 |
| ASELAGE STEVE | Director | 11/06/2020 | 474,375 |
| ASELAGE STEVE | Director | 11/05/2020 | 53,150 |
| Heerma Peter | Chief Commercial Officer | 10/05/2020 | 42,338 |
| Heerma Peter | Chief Commercial Officer | 10/02/2020 | 41,353 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 09/23/2020 | 27,720 |
| Rosenberg Noah L. | Chief Medical Officer | 09/23/2020 | 13,860 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 09/23/2020 | 27,720 |
| Clague Laura | Chief Financial Officer | 09/23/2020 | 27,720 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 09/22/2020 | 27,885 |
| Rosenberg Noah L. | Chief Medical Officer | 09/22/2020 | 13,943 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 09/22/2020 | 27,885 |
| Clague Laura | Chief Financial Officer | 09/22/2020 | 27,885 |
| Dube Eric M | Chief Executive Officer | 09/21/2020 | 208,319 |
| ASELAGE STEVE | Director | 08/05/2020 | 49,200 |
| Rosenberg Noah L. | Chief Medical Officer | 07/28/2020 | 17,826 |
| ASELAGE STEVE | Director | 06/25/2020 | 200,000 |
| ASELAGE STEVE | Director | 05/14/2020 | 46,206 |
| ASELAGE STEVE | Director | 05/13/2020 | 66,674 |
| ASELAGE STEVE | Director | 05/12/2020 | 17,160 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/11/2020 | 7,849 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/12/2020 | 17,960 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/12/2020 | 22,885 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/11/2020 | 12,154 |
| Clague Laura | Chief Financial Officer | 05/12/2020 | 30,401 |
| Clague Laura | Chief Financial Officer | 05/11/2020 | 18,687 |
| Rosenberg Noah L. | Chief Medical Officer | 05/12/2020 | 8,951 |
| ASELAGE STEVE | Director | 05/05/2020 | 39,700 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 03/10/2020 | 48,327 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 03/10/2020 | 52,570 |
| Clague Laura | Chief Financial Officer | 03/10/2020 | 60,080 |
| Rosenberg Noah L. | Chief Medical Officer | 03/05/2020 | 27,487 |
| ASELAGE STEVE | Director | 03/05/2020 | 66,939 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/18/2020 | 20,687 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/14/2020 | 20,900 |
| ASELAGE STEVE | Director | 02/05/2020 | 41,550 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/08/2020 | 11,355 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/07/2020 | 10,455 |
| Dube Eric M | Chief Executive Officer | 01/08/2020 | 56,775 |
| Dube Eric M | Chief Executive Officer | 01/07/2020 | 52,275 |
| ASELAGE STEVE | Director | 11/29/2019 | 69,552 |
| Rosenberg Noah L. | Chief Medical Officer | 07/31/2019 | 25,087 |
| Rosenberg Noah L. | Chief Medical Officer | 07/30/2019 | 24,775 |
| McFarlane Neil F. | Chief Operating Officer | 05/15/2019 | 17,496 |
| McFarlane Neil F. | Chief Operating Officer | 05/16/2019 | 18,411 |
| Clague Laura | Chief Financial Officer | 05/16/2019 | 23,387 |
| Clague Laura | Chief Financial Officer | 05/15/2019 | 22,225 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/15/2019 | 14,421 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 05/14/2019 | 14,455 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/15/2019 | 9,298 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 05/14/2019 | 9,319 |
| ASELAGE STEVE | Director | 05/14/2019 | 32,698 |
| ASELAGE STEVE | Director | 05/15/2019 | 32,753 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/19/2019 | 26,900 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/15/2019 | 26,800 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/12/2019 | 19,006 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 02/11/2019 | 18,921 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/12/2019 | 21,328 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/11/2019 | 21,230 |
| Clague Laura | Chief Financial Officer | 02/12/2019 | 21,844 |
| Clague Laura | Chief Financial Officer | 02/11/2019 | 21,743 |
| ASELAGE STEVE | Chief Executive Officer | 02/12/2019 | 22,898 |
| ASELAGE STEVE | Chief Executive Officer | 02/11/2019 | 22,770 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/09/2019 | 17,865 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/08/2019 | 18,068 |
| McFarlane Neil F. | Chief Operating Officer | 12/20/2018 | 248,333 |
| ASELAGE STEVE | Chief Executive Officer | 12/21/2018 | 134,829 |
| ASELAGE STEVE | Chief Executive Officer | 12/20/2018 | 135,958 |
| Clague Laura | Chief Financial Officer | 12/21/2018 | 81,860 |
| Clague Laura | Chief Financial Officer | 12/20/2018 | 82,804 |
| ASELAGE STEVE | Chief Executive Officer | 12/07/2018 | 240 |
| McFarlane Neil F. | Chief Operating Officer | 11/14/2018 | 237,314 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 11/15/2018 | 60,816 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 11/14/2018 | 59,330 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 11/15/2018 | 60,800 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 11/14/2018 | 59,329 |
| Clague Laura | Chief Financial Officer | 11/15/2018 | 91,167 |
| Clague Laura | Chief Financial Officer | 11/14/2018 | 88,970 |
| ASELAGE STEVE | Chief Executive Officer | 11/15/2018 | 134,969 |
| ASELAGE STEVE | Chief Executive Officer | 11/14/2018 | 131,735 |
| ASELAGE STEVE | Chief Executive Officer | 08/31/2018 | 104,400 |
| ASELAGE STEVE | Chief Executive Officer | 08/31/2018 | 384,000 |
| ASELAGE STEVE | Chief Executive Officer | 03/07/2018 | 1,668 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 02/14/2018 | 22,232 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 01/05/2018 | 22,646 |
| McFarlane Neil F. | Chief Operating Officer | 08/16/2017 | 31,005 |
| ASELAGE STEVE | Chief Executive Officer | 06/14/2017 | 89,250 |
| ASELAGE STEVE | Chief Executive Officer | 11/22/2016 | 68,160 |
| ASELAGE STEVE | Chief Executive Officer | 11/21/2016 | 105,000 |
| Shih Alvin | EVP of Research & Development | 09/01/2016 | 142,059 |
| Shih Alvin | EVP of Research & Development | 06/01/2016 | 155,284 |
| Meckler Jeffrey A | Director | 03/04/2016 | 76,564 |
| Meckler Jeffrey A | Director | 03/03/2016 | 144,500 |
| Shih Alvin | EVP of Research & Development | 03/01/2016 | 125,569 |
| Shih Alvin | EVP of Research & Development | 12/09/2015 | 182,262 |
| ASELAGE STEVE | Chief Executive Officer | 11/10/2015 | 561,600 |
| ASELAGE STEVE | Chief Executive Officer | 11/09/2015 | 563,100 |
| VALEUR JENSEN MARGARET E | General Counsel | 11/02/2015 | 1,022,949 |
| Shih Alvin | EVP of Research & Development | 10/06/2015 | 176,073 |
| Shih Alvin | EVP of Research & Development | 06/26/2015 | 912,850 |
| Plotkin Horacio | Chief Medical Officer | 12/12/2014 | 21,146 |
| Meckler Jeffrey A | Director | 11/25/2014 | 129,050 |
| Richardson Steven Gary | Director | 11/21/2014 | 51,118 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/20/2014 | 1,105,989 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/19/2014 | 2,817,093 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/18/2014 | 2,343,501 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/17/2014 | 941,100 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/14/2014 | 1,022,790 |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 11/21/2014 | 2,126,443 |
| ASELAGE STEVE | Chief Executive Officer | 11/20/2014 | 10,660 |
| ASELAGE STEVE | Chief Executive Officer | 11/21/2014 | 73,950 |
| Golding Cornelius E | Director | 11/19/2014 | 18,000 |
| Plotkin Horacio | Chief Medical Officer | 11/17/2014 | 78,594 |
| Shkreli Martin | Chief Executive Officer | 10/01/2014 | 202,665 |
| Shkreli Martin | Chief Executive Officer | 10/01/2014 | 3,000 |
| Shkreli Martin | Chief Executive Officer | 09/30/2014 | 37,680 |
| Shkreli Martin | Chief Executive Officer | 09/22/2014 | 378,707 |
| Shkreli Martin | Chief Executive Officer | 09/19/2014 | 212,035 |
| Shkreli Martin | Chief Executive Officer | 09/17/2014 | 68,740 |
| Shkreli Martin | Chief Executive Officer | 09/16/2014 | 80,190 |
| Paley Jeffrey | Director | 08/14/2014 | 245,598 |
| Shkreli Martin | Chief Executive Officer | 05/30/2014 | 2,578,793 |
| Shkreli Martin | Chief Executive Officer | 05/30/2014 | 4,426,936 |
| Shkreli Martin | Chief Executive Officer | 04/04/2014 | 157,145 |
| Shkreli Martin | Chief Executive Officer | 04/03/2014 | 508,442 |
| Shkreli Martin | Chief Executive Officer | 04/02/2014 | 240,615 |
| Shkreli Martin | Chief Executive Officer | 03/24/2014 | 70,440 |
| Shkreli Martin | Chief Executive Officer | 03/20/2014 | 89,850 |
| Shkreli Martin | Chief Executive Officer | 03/19/2014 | 64,557 |
| Shkreli Martin | Chief Executive Officer | 03/14/2014 | 69,445 |
| Shkreli Martin | Chief Executive Officer | 03/11/2014 | 504,387 |
| Shkreli Martin | Chief Executive Officer | 03/10/2014 | 206,711 |
| Shkreli Martin | Chief Executive Officer | 03/07/2014 | 45,618 |
| Shkreli Martin | Chief Executive Officer | 03/06/2014 | 29,528 |
| Shkreli Martin | Chief Executive Officer | 03/05/2014 | 73,906 |
| Shkreli Martin | Chief Executive Officer | 02/21/2014 | 1,720 |
| Shkreli Martin | Chief Executive Officer | 02/28/2014 | 802,677 |
| Shkreli Martin | Chief Executive Officer | 02/21/2014 | 28,102 |
| Shkreli Martin | Chief Executive Officer | 02/14/2014 | 51,106 |
| Shkreli Martin | Chief Executive Officer | 02/06/2014 | 19,832 |
| Shkreli Martin | Chief Executive Officer | 01/14/2014 | 86,694 |
| Shkreli Martin | Chief Executive Officer | 09/12/2013 | 25,002 |
| Shkreli Martin | Chief Executive Officer | 12/31/2013 | 1,050,000 |
| Richardson Steven Gary | Director | 08/15/2013 | 4,995 |
| ASELAGE STEVE | Director | 08/15/2013 | 2,502 |
| Golding Cornelius E | Director | 12/24/2013 | 22,500 |
| Shkreli Martin | Chief Executive Officer | 12/09/2013 | 811 |
| Shkreli Martin | Chief Executive Officer | 12/06/2013 | 830 |
| Shkreli Martin | Chief Executive Officer | 11/26/2013 | 1,021 |
| Shkreli Martin | Chief Executive Officer | 11/22/2013 | 1,818 |
| Richardson Steven Gary | Director | 11/05/2013 | 20,010 |
| Shkreli Martin | Chief Executive Officer | 09/12/2013 | 50,004 |
| Plotkin Horacio | Chief Medical Officer | 08/15/2013 | 9,900 |
| Shkreli Martin | Chief Executive Officer | 08/21/2013 | 17,024 |
| Shkreli Martin | Chief Executive Officer | 08/22/2013 | 6,622 |
| PANOFF MARC L | Chief Financial Officer | 08/15/2013 | 4,950 |
| Shkreli Martin | Chief Executive Officer | 03/11/2013 | 1,880 |
| Shkreli Martin | Chief Executive Officer | 03/06/2013 | 425 |
| Shkreli Martin | Chief Executive Officer | 03/04/2013 | 4,425 |
| Shkreli Martin | Chief Executive Officer | 02/20/2013 | 4,662 |
| Shkreli Martin | Chief Executive Officer | 02/14/2013 | 360,000 |
| Shkreli Martin | Chief Executive Officer | 02/12/2013 | 5,000 |
| Shkreli Martin | Chief Executive Officer | 12/26/2012 | 355 |
| Shkreli Martin | Chief Executive Officer | 12/17/2012 | 769 |
Load More Insider Transactions
FUNDS WITH A POSITION IN TRAVERE THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 7,917,860 | 0.00181% | 3.73% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 3,081,014 | 0.04% | 54.5% | Other |
| D. E. SHAW & CO., INC. | 1,658,147 | 0.01% | 68.59% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,521,730 | 0.00143% | 5.63% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 1,094,000 | 0.05% | 302.92% | Event Driven, Value |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | 0.00931% | New | Other |
| PALO ALTO INVESTORS LP | 110,719 | 0.09% | -33.33% | Other |
| ALPS ADVISORS INC | 47,055 | 0.00333% | -15.02% | Other |
| FISHER ASSET MANAGEMENT, LLC | 43,182 | 0.00021% | No change | Other |
| ROYCE & ASSOCIATES LP | 41,641 | 0.00346% | 127.06% | Value |
| AQR CAPITAL MANAGEMENT LLC | 17,183 | 0.00029% | -64.39% | Other |
CHANGE IN SHARES OUTSTANDING FOR TRAVERE THERAPEUTICS INC
STOCK BUYBACKS FOR TRAVERE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.25%
1Q
06/30/2023
0.65%
2Q
03/31/2023
12.21%
3Q
12/31/2022
19.12%
4Q
09/30/2022
19.47%
5Q
06/30/2022
20.21%
6Q
03/31/2022
21.17%
7Q
12/31/2021
24.11%
8Q
09/30/2021
25.81%
9Q
06/30/2021
26.30%
10Q
03/31/2021
35.95%
11Q
12/31/2020
49.15%
12Q
09/30/2020
50.21%
13Q
06/30/2020
70.89%
14Q
03/31/2020
75.49%
15Q
12/31/2019
77.78%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TRAVERE THERAPEUTICS INC
LOADING...